Determination of Colistin Resistance by Simple Disk Diffusion Test Using Modified Mueller-Hinton Agar

키워드

참고문헌 (24)

1. Bergen PJ, "Colistin methanesulfonate is an inactive prodrug of colistin against Pseudomonas aeruginosa", Antimicrob Agents Chemother, 50, pp.1953~1958 (2006)
2. Stojanoski V, "Structure of the catalytic domain of the colistin resistance enzyme MCR-1", BMC Biol, 14, pp.81~ (2016)
3. Falagas ME, "Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections", Clin Infect Dis, 40, pp.1333~1341 (2005)
4. Gupta S, "Colistin and polymyxin B : a re-emergence", Indian J Crit Care Med, 13, pp.49~53 (2009)
5. Huang J, "Intravenous colistin sulfate: a rarely used form of polymyxin E for the treatment of severe multidrug-resistant Gram-negative bacterial infections", Scand J Infect Dis, 42, pp.260~265 (2010)
6. Bosso JA, "Toxicity of colistin in cystic fibrosis patients", DICP, 25, pp.1168~1170 (1991)
7. Poirel L, "Polymyxins: antibacterial activity, susceptibility testing, and resistance mechanisms encoded by plasmids or chromosomes", Clin Microbiol Rev, 30, pp.557~596 (2017)
8. Suzuki T, "The chemical structure of polymyxin E : the identities of polymyxin E1 with colistin A and of polymyxin E2 with colistin B", J Biochem, 57, pp.226~227 (1965)
9. Walkty A, "In vitro activity of colistin (polymyxin E) against 3,480 isolates of gram-negative bacilli obtained from patients in Canadian hospitals in the CANWARD Study, 2007-2008", Antimicrob Agents Chemother, 53, pp.4924~4926 (2009)
10. Yu Z, "Antibacterial mechanisms of polymyxin and bacterial resistance", Biomed Res Int, 2015, pp.679109~ (2015)
11. Bialvaei AZ, "Colistin, mechanisms and prevalence of resistance", Curr Med Res Opin, 31, pp.707~721 (2015)
12. de Louvois J, "Factors influencing the assay of antimicrobial drugs in clinical samples by the agar plate diffusion method", J Antimicrob Chemother, 9, pp.253~265 (1982)
13. Dafopoulou K, "Comparative evaluation of colistin susceptibility testing methods among carbapenem-nonsusceptible Klebsiella pneumoniae and Acinetobacter baumannii clinical isolates", Antimicrob Agents Chemother, 59, pp.4625~4630 (2015)
14. Balaji V, "Polymyxins: antimicrobial susceptibility concerns and therapeutic options", Indian J Med Microbiol, 29, pp.230~242 (2011)
15. Galani I, "Colistin susceptibility testing by Etest and disk diffusion methods", Int J Antimicrob Agents, 31, pp.434~439 (2008)
16. Moskowitz SM, "PmrAB, a two-component regulatory system of Pseudomonas aeruginosa that modulates resistance to cationic antimicrobial peptides and addition of aminoarabinose to lipid A", J Bacteriol, 186, pp.575~579 (2004)
17. Moskowitz SM, "Colistin susceptibility testing: evaluation of reliability for cystic fibrosis isolates of Pseudomonas aeruginosa and Stenotrophomonas maltophilia", J Antimicrob Chemother, 65, pp.1416~1423 (2010)
18. Simar S, "Colistin and polymyxin B minimal inhibitory concentrations determined by Etest found unreliable for gram-negative bacilli", Ochsner J, 17, pp.239~242 (2017)
19. Tan T, "Comparison of Etest, Vitek and agar dilution for susceptibility testing of colistin", Clin Microbiol Infect, 13, pp.541~544 (2007)
20. Bakthavatchalam YD, "Challenges, issues and warnings from CLSI and EUCAST working group on Polymyxin susceptibility testing", J Clin Diagn Res, pp.DL03~DL4 (2017)
21. CLSI, "Performance standards for antimicrobial susceptibility testing" (2018), Clinical and Laboratory Standards Institute
22. Humphries RM, "Susceptibility testing of the polymyxins : where are we now", Pharmacotherapy, 35, pp.22~27 (2015)
23. Turlej-Rogacka A, "Evaluation of colistin stability in agar and comparison of four methods for MIC testing of colistin", Eur J Clin Microbiol Infect Dis, 37, pp.345~353 (2018)
24. Uyttendaele M, "Evaluation of the antimicrobial activity of protamine", Food Microbiol, 11, pp.417~427 (1994)

관련 논문AI추천